Literature DB >> 3917474

Induction of proliferation in vitro of resting human natural killer cells: expression of surface activation antigens.

L London, B Perussia, G Trinchieri.   

Abstract

In this report, we show that resting human peripheral blood NK cells, positively enriched with antibody B73.1, can be induced to proliferate in vitro in short-term cultures, and newly express membrane activation antigens. B73.1+ NK cells, cultured for 6 days in the presence of conditioned medium containing IL 2 and irradiated B lymphoblastoid cells, show significant [3H]TdR incorporation beginning on day 4. At that time, a large proportion of the cells express HLA-DR and 4F2 antigens, and transferrin and IL 2 receptors, all detectable at high density by indirect immunofluorescence with the use of monoclonal antibodies. These cells maintain their ability to lyse target cells spontaneously or in the presence of antibodies. By two-color immunofluorescence and cell cycle analysis combined with indirect immunofluorescence, we demonstrate directly that the activation antigens are expressed on all NK (B73.1+) cells in the S/G2/M phases of the cell cycle, and on only a proportion of those in the G0/G1 phases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917474

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.

Authors:  F A Karlsson; T H Tötterman
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

2.  Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes.

Authors:  F Malavasi; C Tetta; A Funaro; G Bellone; E Ferrero; A C Franzone; P Dellabona; R Rusci; L Matera; G Camussi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Generation of non-MHC restricted killing in cultures stimulated with B cells from chronic lymphocytic leukaemia patients: phenotypic characterization of the precursor and effector cells.

Authors:  L Matera; R Foa; F Malavasi; G Bellone; A Funaro; F Veglia; D Santoli
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

Review 4.  Abnormal expansions of granular lymphocytes: reactive lymphocytosis or chronic leukemia? Case report and literature review.

Authors:  G Gastl; H Rumpold; D Kraft; C Gattringer; G Schuler; R Margreiter; F Schmalzl; C Huber
Journal:  Blut       Date:  1986-02

5.  Natural killer (NK)-cell activity in sorted subsets of peripheral blood mononuclear cells from patients with severe combined immunodeficiency.

Authors:  R J ten Berge; P T Schellekens; A Budding-Koppenol; L J Dooren; J M Vossen
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

Review 6.  The role of iron and iron binding proteins in lymphocyte physiology and pathology.

Authors:  J D Kemp
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

7.  Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.

Authors:  B Gudbjörnsson; R Hällgren; O Nettelbladt; R Gustafsson; A Mattsson; E af Geijerstam; T H Tötterman
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

8.  Ultrastructural localization and internalization of proteoglycan epitopes in a human non-Hodgkin (B) lymphoma.

Authors:  J Timár; I Kovalszky; A Bánkfalvi; L Kopper
Journal:  Histochemistry       Date:  1990

9.  Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis.

Authors:  T Matsumoto; K Iwasaki
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

10.  Natural killer (NK) cell immunodeficiency in patients with chronic myelogenous leukemia. II. Successful cloning and amplification of natural killer cells.

Authors:  Y Fujimiya; W C Chang; A Bakke; D Horwitz; P K Pattengale
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.